Chronic Lymphocytic Leukemia (CLL)-Derived Extracellular Vesicles Educate Endothelial Cells to Become IL-6-Producing, CLL-Supportive Cells

We hypothesized that via extracellular vesicles (EVs), chronic lymphocytic leukemia (CLL) cells turn endothelial cells into CLL-supportive cells. To test this, we treated vein-derived (HUVECs) and artery-derived (HAOECs) endothelial cells with EVs isolated from the peripheral blood of 45 treatment-n...

Full description

Bibliographic Details
Published in:	Biomedicines
Main Authors:	Orit Uziel, Lian Lipshtein, Zinab Sarsor, Einat Beery, Shaked Bogen, Meir Lahav, Alon Regev, Vitali Kliminski, Roded Sharan, Asia Gervits, Lorenzo Federico Signorini, Shai Shimony, Pia Raanani, Uri Rozovski
Format:	Article
Language:	English
Published:	MDPI AG 2024-06-01
Subjects:	CLL EVs endothelial cells
Online Access:	https://www.mdpi.com/2227-9059/12/7/1381

Similar Items

IGHV Mutational Status in a Cohort of Bulgarian CLL Patients: High Unmutated CLL Prevalence in North-East Bulgaria
by: Yosifova A, et al.
Published: (2024-09-01)

The Influence of CLL on EFL Learners’ Speaking Skill
by: Muhammad Ilyas
Published: (2018-08-01)

Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial
by: Alexander Egle, et al.
Published: (2019-04-01)

A Retrospective Analysis of CLL Patients in a Romanian Hematology Center
by: Ana-Maria IORDAN, et al.
Published: (2025-06-01)

Students’ Perception on The Implementation of Orai Application In CLL Method in Teaching Speaking
by: Halimah, et al.
Published: (2022-05-01)

Case report: HSV lymphadenitis in immunocompromised patient with CLL
by: Talal Al-Assil, et al.
Published: (2024-12-01)

Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival
by: Nancy Nisticò, et al.
Published: (2020-09-01)

K-562 Extracellular Vesicles Partially Protect Intact Cells from Oxidative Stress and Provide Limited Resistance to Imatinib
by: Jiana Sbiet, et al.
Published: (2025-08-01)

Current strategies for the diagnosis and management of chronic lymphocytic leukemia (CLL), with a focus on poor-risk CLL: A review
by: Fabienne Mc Clanahan, et al.
Published: (2011-05-01)

Current strategies for the diagnosis and management of chronic lymphocytic leukemia (CLL), with a focus on poor-risk CLL: A review
by: Fabienne Mc Clanahan, et al.
Published: (2011-06-01)

Challenges in Diagnosis and Clinical Management of COVID-19 in Patient with B-Cell Chronic Lymphocytic Leukemia (CLL): Report of One Case
by: Vincenzo Visco, et al.
Published: (2022-03-01)

Hypodiploidy: A Poor Prognostic Cytogenetic Marker in B-CLL
by: Andrew Ruggero, et al.
Published: (2025-07-01)

BTLA Expression in CLL: Epigenetic Regulation and Impact on CLL B Cell Proliferation and Ability to IL-4 Production
by: Lidia Karabon, et al.
Published: (2021-11-01)

Diagnosis of B-CLL Leukemia Using Fractal Dimension
by: Tohid Yousefzadeh Hassanluie, et al.
Published: (2017-07-01)

An overview of prognostic markers in patients with CLL
by: Julie Braish, et al.
Published: (2024-05-01)

Successful treatment of a CLL associated IgM hyper-viscosity syndrome: A rare case
by: Toufic Tannous, et al.
Published: (2024-01-01)

Frontline Treatment of the Young, Fit Patient with CLL: A Canadian Perspective
by: Jacqueline Costello, et al.
Published: (2021-09-01)

NF-kB and the CLL microenvironment
by: Alice O’Donnell, et al.
Published: (2023-03-01)

Venetoclax-Based Regimens in CLL: Immunoglobulin G Levels, Absolute Neutrophil Counts, and Infectious Complications
by: Wojciech Szlasa, et al.
Published: (2025-06-01)

Cytokine Release Ensuing Interaction Between Human Peripheral Blood Mononuclears and Epstein-Barr Virus Transformed B-CLL Cell Line
by: Hanna Bessler, et al.
Published: (2020-08-01)

Effect of Curcumin on Growth Inhibition and Gene Expression Reduction in Chronic Lymphocytic Leukemia Cells(CLL-CII)
by: AM Gholamian, et al.
Published: (2020-04-01)

EUROCOVER-CLL: Reimbursement and accessibility of new treatments in relapsed/refractory chronic lymphocytic leukemia
by: Magdalena Monica, et al.
Published: (2025-09-01)

Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study
by: Eleonora Roncaglia, et al.
Published: (2025-07-01)

The Combination of Ibrutinib with BH3 Mimetics or Dichloroacetate Is Effective in B-CLL
by: Joaquín Marco-Brualla, et al.
Published: (2025-08-01)

Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients
by: Jonas S. Heitmann, et al.
Published: (2024-11-01)

The role of the CLL-1 protein in disease monitoring in patients diagnosed with acute myeloid leukaemia and myelodysplastic syndrome
by: Ewa Dobak, et al.
Published: (2024-10-01)

Efficacy and safety of CAR-T therapy targeting CLL1 in patients with extramedullary diseases of acute myeloid leukemia
by: Yifan Zhao, et al.
Published: (2024-10-01)

The Mysterious Actor—γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL)
by: Michał K. Zarobkiewicz, et al.
Published: (2022-02-01)

Community Language Learning (CLL) in Tertiary Level: A Learner Friendly Approach to ELT in Bangladesh
by: Tazreen Jahan Bari
Published: (2020-12-01)

Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)
by: Kübra Kaban, et al.
Published: (2021-11-01)

Spatial organization and early signaling of the B-cell receptor in CLL
by: Yamit Shorer Arbel, et al.
Published: (2022-08-01)

MicroRNA Deregulation and Immune Checkpoint Interactions in Common Variable Immunodeficiency and CLL-Associated Secondary Immunodeficiency
by: Paulina Mertowska, et al.
Published: (2025-10-01)

Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
by: Meng Zhang, et al.
Published: (2025-01-01)

Modified CD15/CD16-CLL1 inhibitory CAR-T cells for mitigating granulocytopenia toxicities in the treatment of acute myeloid leukemia
by: Rui Zhang, et al.
Published: (2025-02-01)

Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLL
by: Carlos Cuesta-Mateos, et al.
Published: (2021-01-01)

Expression of ZAP 70 in Chronic Lymphocytic Leukemia (CLL) and its Correlation with Clinical Stages
by: Zahra Tasleem, et al.
Published: (2024-01-01)

Infectious complications distribution following CLL1 CAR-T cell therapy for acute myeloid leukemiass
by: Jianmei Xu, et al.
Published: (2025-03-01)

Synthesis and Pro-Apoptotic Effects of Nitrovinylanthracenes and Related Compounds in Chronic Lymphocytic Leukaemia (CLL) and Burkitt’s Lymphoma (BL)
by: Andrew J. Byrne, et al.
Published: (2023-12-01)

A case of early ocular manifestation of maculopathy in a 37 yr old male patient of CLL
by: Sufia Ahmad Khan, et al.
Published: (2014-08-01)

Lysosome-Disrupting Agents in Combination with Venetoclax Increase Apoptotic Response in Primary Chronic Lymphocytic Leukemia (CLL) Cells Mediated by Lysosomal Cathepsin D Release and Inhibition of Autophagy
by: Madhumita S. Manivannan, et al.
Published: (2024-06-01)